MicrobiologybioRxiv
NSC95397 is a Novel HIV-1 Latency Reversing Agent
R. Nichols Doyle, V. Yang, Y. I. Kayode…·O. I. Fregoso
This study identifies NSC95397 as a novel HIV-1 latency reversing agent that synergizes with existing LRAs and targets previously unrecognized pathways.
DOI 10.3390/v16111783